U.S. federal trademark · Serial No. 98209503 · Reg. No. 8424103
Pharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for use in human therapeutics for the treatment of Sickle Cell Disease, Alpha-1 Antitrypsin Deficiency, and Glycogen Storage Disease Ia
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.